# Fremanezumab

## Ajovy inj 225mg/1.5mL

##### 臨採

| TAH Drug Code      | [IAJO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAJO){:target="_blank"}                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For the preventive treatment of migraine in adults.                                                                                      |
| Dosing             | 225 mg monthly, or 675 mg every 3 months (quarterly).                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                            |
| Contraindications  | Patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients.                                                 |
| Adverse Effects    | Common Dermatologic: Injection site disorder (43% to 45% ) Serious Immunologic: Anaphylaxis, Hypersensitivity reaction Other: Angioedema |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/fremanezumab-drug-information){:target="_blank"}                                            |

